Press news Biocartis Group NV: Biocartis and Exact Sciences Agree to End Collaboration Due to Changed Market Circumstances

NEXT STORY
AzurRx BioPharma Provides Insight into Drawbacks of Using Porcine Products in Production of Pharmaceuticals and Medicinals, Offers Update on Efforts to Produce Synthetic Alternatives
PREV STORY
Sensus Healthcare to Host Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference

author_avatar
NASDAQ Market News

COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™

author_avatar
NASDAQ Market News

Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News